Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity

• Shotaro Sasaki,

  Affiliation Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060–0812, Japan

  ⨯
• Masaki Kobayashi,

  Affiliation Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060–0812, Japan

  ⨯
• Yuya Futagi,

  Affiliation Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060–0812, Japan

  ⨯
• Jiro Ogura,

  Affiliation Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060–0812, Japan

  ⨯
• Hiroaki Yamaguchi,

  Affiliation Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060–0812, Japan

  ⨯
• Ken Iseki

  * E-mail: ken-i@pharm.hokudai.ac.jp

  Affiliations Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060–0812, Japan, Department of Pharmacy, Hokkaido University Hospital, Sapporo 060–8648, Japan

  ⨯